NYSE$AFL
Aflac Inc · Q3 2025 earnings
Q3 2025 earnings · · After market close · Investor relations
Briefing
Aflac reported Q3 2025 total revenues of $4.74B with strong Japan and U.S. supplemental health results.
Total revenues were $4.74 billion in the third quarter as Japan cancer and medical products and U.S. voluntary benefits remained core earnings drivers. The company continued capital returns through dividends and buybacks while managing yen exposure.
- Q3 total revenues $4.74B across Japan and U.S. segments.
- Supplemental health products anchor persistency and cash flows.
- Investment income and hedge programs affect reported EPS quarter to quarter.
- Capital returns remain a priority alongside reserve strength.
Headline financials
Revenue & EPS history
Aflac · Revenue · Quarterly
$4.74B
Revenue by segment
Aflac · $5.07B total across 3 segments · Q1 2022
- Aflac Japan Revenue$3.4B—67.0%
- Aflac U.S. Revenue$1.6B—31.5%
- Corporate and Other Revenue$74M-10.8%1.5%
Forward guidance
The quarterly filing discusses operating priorities, liquidity, and risks; formal multi-year guidance varies by issuer.
Tailwinds
- Management outlines strategic priorities and capital allocation.
- Segment or product commentary supports the investment narrative.
Headwinds
- Macro, rates, or input costs may affect margins.
- One-time items can affect quarter-over-quarter comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2025
+0.6%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+1.7%
Avg return
30 days after
63%
46 / 73 earnings
Positive
+9.4%
Q1 2012
Best reaction
-11.1%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.6% | -1.5% | -3.3% | |
| Q4 2025 | +3.4% | +2.0% | -2.1% | |
| Q3 2025 | +2.3% | +4.4% | +0.4% | |
| Q2 2025 | +3.4% | +5.3% | +8.1% | |
| Q1 2025 | -4.7% | -2.6% | -4.7% | |
| Q4 2024 | -3.9% | -4.0% | +1.0% | |
| Q3 2024 | -4.7% | -5.0% | +3.6% | |
| Q2 2024 | +6.6% | +1.9% | +15.7% | |
| Q1 2024 | +0.5% | +1.3% | +7.4% | |
| Q4 2023 | -11.1% | -11.0% | -6.2% | |
| Q3 2023 | +4.6% | +4.2% | +5.8% | |
| Q2 2023 | +5.4% | +6.2% | +3.1% | |
| Q1 2023 | +5.6% | +7.0% | -1.9% | |
| Q4 2022 | -6.3% | -5.3% | -6.9% | |
| Q3 2022 | +3.1% | +3.7% | +11.0% | |
| Q2 2022 | +2.5% | +3.7% | +3.7% | |
| Q1 2022 | -2.5% | -5.7% | -0.6% | |
| Q4 2021 | +1.4% | +3.8% | -4.4% | |
| Q3 2021 | -3.1% | -4.0% | -2.7% | |
| Q2 2021 | +3.4% | +1.7% | +6.1% | |
| Q1 2021 | +1.3% | +1.8% | +5.9% | |
| Q4 2020 | -1.2% | -0.1% | +7.9% | |
| Q3 2020 | -7.1% | -7.7% | +24.0% | |
| Q2 2020 | +0.2% | -2.4% | +1.2% | |
| Q1 2020 | -1.5% | -5.4% | -3.5% | |
| Q4 2019 | +2.4% | +1.8% | -20.1% | |
| Q3 2019 | +1.5% | +2.1% | +2.9% | |
| Q2 2019 | -0.1% | -1.9% | -10.3% | |
| Q1 2019 | +1.3% | +3.0% | +6.4% | |
| Q4 2018 | +1.2% | +1.8% | +3.8% | |
| Q3 2018 | -4.7% | -4.5% | +0.5% | |
| Q2 2018 | +5.8% | +6.3% | +6.6% | |
| Q1 2018 | +1.1% | +0.9% | +0.4% | |
| Q4 2017 | +1.3% | -2.7% | -1.2% | |
| Q3 2017 | -1.1% | -0.9% | +0.5% | |
| Q2 2017 | +2.6% | +4.6% | +4.6% | |
| Q1 2017 | +0.1% | +0.3% | +0.1% | |
| Q4 2016 | -4.5% | -2.5% | +2.6% | |
| Q3 2016 | -1.8% | -2.0% | +2.8% | |
| Q2 2016 | -1.5% | -2.4% | -0.8% | |
| Q1 2016 | +2.1% | — | — | |
| Q4 2015 | -1.2% | — | — | |
| Q3 2015 | +0.7% | — | — | |
| Q2 2015 | +4.9% | — | — | |
| Q1 2015 | -0.2% | — | — | |
| Q4 2014 | +4.3% | — | — | |
| Q3 2014 | +1.9% | — | — | |
| Q2 2014 | -3.6% | — | — | |
| Q1 2014 | +1.4% | — | — | |
| Q4 2013 | +1.7% | — | — | |
| Q3 2013 | -2.2% | — | — | |
| Q2 2013 | +1.1% | — | — | |
| Q1 2013 | +3.7% | — | — | |
| Q4 2012 | -3.2% | — | — | |
| Q3 2012 | -1.5% | — | — | |
| Q4 2011 | +4.2% | — | — | |
| Q2 2012 | -2.7% | — | — | |
| Q1 2012 | +9.4% | — | — | |
| Q3 2011 | -0.1% | — | — | |
| Q2 2011 | -10.8% | — | — | |
| Q1 2011 | +1.9% | — | — | |
| Q4 2010 | +2.9% | — | — | |
| Q3 2010 | -1.2% | — | — | |
| Q2 2010 | +0.3% | — | — | |
| Q1 2009 | +7.5% | — | — | |
| Q1 2010 | +1.8% | — | — | |
| Q4 2007 | +1.7% | — | — | |
| Q4 2009 | +1.7% | — | — | |
| Q3 2009 | +3.1% | — | — | |
| Q3 2008 | +3.1% | — | — | |
| Q2 2008 | +2.9% | — | — | |
| Q4 2008 | +2.9% | — | — | |
| Q2 2009 | +2.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro